Smart Pills Patient Monitoring Market Size

  • Report ID: 3864
  • Published Date: Jul 24, 2024
  • Report Format: PDF, PPT

Smart Pills Patient Monitoring Market Size

Smart Pills Patient Monitoring Market size was over USD 5.8 Billion in 2023 and is expected to exceed USD 39.46 Billion by the end of 2036, witnessing over 15.9% CAGR during the forecast period i.e., between 2024-2036. In the year 2024, the industry size of smart pills patient monitoring is evaluated at USD 6.63 Billion. The growth of the market can be attributed to the increasing proportion of various types of chronic disorders throughout the world. For instance, chronic diseases constitute a significant global health issue. Globally, they caused over 42 million deaths in 2019. Its proportion has increased over time, from roughly 67% of global mortality in 2010 to 78% in 2019. Apart from this, the worldwide rising patient pool of lifestyle-related diseases such as gastrointestinal reflux disease (GERD), obesity, gastric ulcers, and so on is also estimated to radically fuel the growth of the global smart pills patient monitoring market in the coming years.

In addition to these, factors that are believed to fuel the market growth of smart pills patient monitoring include the rising ratio of aged people across the globe, along with a soaring focus on patient convenience, and the worldwide expanding demand for minimally invasive procedures. For instance, worldwide, there are close to 13 million minimally invasive procedures performed each year. Additionally, a rise in technological development such as integrated circuit miniaturization, as well as surging research and development investments in developing smart pills is also predicted to present the potential for market expansion over the projected period.


Smart Pills Patient Monitoring Market Overview
Get more information on this report: Request Free Sample PDF

Browse Key Market Insights with Data Illustration:


Author Credits:  Radhika Pawar


  • Report ID: 3864
  • Published Date: Jul 24, 2024
  • Report Format: PDF, PPT

Frequently Asked Questions (FAQ)

In the year 2024, the industry size of smart pills patient monitoring is evaluated at USD 6.63 Billion.

The smart pills patient monitoring market size was over USD 5.8 Billion in 2023 and is expected to exceed USD 39.46 Billion by the end of 2036, witnessing over 15.9% CAGR during the forecast period i.e., between 2024-2036. Increasing ratio of various types of chronic disorders, rising prevalence of gastrointestinal reflux disease (GERD), and worldwide increase in neurological disorders are the major factors driving the market growth.

North America is likely to dominate majority industry share by 2036, attributed to higher frequency of colorectal cancer amongst people, driven by rise in sedentary lifestyles, and rapidly surging ratio of geriatric populace in the region.

Medtronic plc, AbbVie Inc., Novartis AG, CapsoVision, Inc., Medimetrics, SA de CV, TauRx Pharmaceuticals Ltd, Otsuka Pharmaceutical Co. Ltd., FUJIFILM Holdings Corporation,
Inquiry Before Buying Request Free Sample
logo
  GET A FREE SAMPLE

FREE Sample Copy includes market overview, growth trends, statistical charts & tables, forecast estimates, and much more.

 Request Free Sample Copy

Have questions before ordering this report?

Inquiry Before Buying
Inquiry Before Buying Request Free Sample